Tumour control and Quality of Life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy

Localized vaginal/uterine rhabdomyosarcoma—results of a pooled analysis from four international cooperative groups

“…None of urogenital RMS presented ≥ grade 3 toxicity. However, only 10 patients with urogenital RMS were included in the study with a median follow‐up of 55 months …”

The Evolving Role of Proton Beam Therapy for Sarcomas

“…Interestingly, in chordomas and chondrosarcomas, HQL was not adversely affected by proton therapy [62]. In children with RMS treated with protons, HQL after 2 years was similar when compared with a healthy cohort [23].…”

“…Leiser et al [23] recently published clinical outcomes of 83 children with RMS treated with PBS. Localisations were predominately parameningeal (55%) and orbital (20%).…”

Defining Clinical Indications of Proton Beam Therapy at National Level in the Kingdom of Saudi Arabia

“…The 5-year LCR was 78.5%, and the 5-year OS rate was approximately 80%, with minimal delayed toxicity. 28 Low Grade Glioma (LGG). With decreased dose bath to growing brain tissue, PBT has manifested excellent survival outcomes without any serious sequelae.…”